Form 4: Arvinas Officer Sells Shares for Tax Withholding

Arvinas Chief Scientific Officer Angela M. Cacace sold 9,657 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• Angela M. Cacace, Chief Scientific Officer at Arvinas, Inc., reported a transaction on May 11, 2026.
• The transaction involved the sale of 9,657 shares of common stock at a price of $9.9374 per share.
• This sale was executed automatically by the issuer to cover tax withholding obligations.
• The tax withholding was associated with the vesting and settlement of one-half of the reporting person's restricted stock units (RSUs) granted on May 9, 2025.
• The sale was not a discretionary trade by the reporting person.
• Following this transaction, Ms. Cacace beneficially owns 182,966 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. The transaction is a routine tax-related sale and not indicative of insider confidence or lack thereof in the company's future prospects.

Positives

• The sale was an automatic process to cover tax obligations, indicating it was not a reflection of negative sentiment towards the company's stock.
• The reporting person continues to beneficially own a significant number of shares (182,966) after the transaction.

Negatives

• A portion of the reporting person's equity award was sold, reducing their direct holdings.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which solely reports a past transaction.

Management Comments

• The sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-half of the reporting person's restricted stock units (RSUs) granted on May 9, 2025.
• The sale does not represent a discretionary trade.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions. This specific transaction appears to be a standard mechanism for executives to manage tax liabilities associated with equity compensation, rather than a strategic decision to divest shares based on company performance.

Stakeholder Impact

• Shareholders: No direct impact on share price is expected from this routine tax-related transaction. The number of shares outstanding remains unchanged.
• Employees: This transaction is specific to the reporting person's equity compensation and does not directly impact other employees.
• Management: Highlights a standard practice for managing executive compensation and tax liabilities.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Stock Sale, Tax Withholding, Restricted Stock Units, Arvinas Inc., ARVN, Angela M. Cacace, Chief Scientific Officer